Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Endocrine/Neuroendocrine Posters

  • You have access
    Extra lymph node extension for predicting higher level of the stimulated serum thyroglobulin before the initial radioactive iodine therapy in papillary thyroid carcinoma
    Jing Wang, Wei Ouyang, Huijuan Feng, Yungang Sun, Juqing Wu, Pan Chen and Yuying Deng
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1321;
  • You have access
    Effectivity and Toxicity of Salvage PRRT with Lu-177 DOTATATE in patients with progressive, metastasized NET
    Simon Rudisile, Astrid Gosewisch, Franz Josef Gildehaus, Guido Boening, Christoph Auernhammer, Peter Bartenstein, Andrei Todica and Harun Ilhan
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1346a;
  • You have access
    Tc-99m MIBI parathyroid imaging: added value of early phase SPECT/CT and does it obviates the need for delayed imaging?
    Hatem Nasr, Abdullah Alqarni and Hussein Rabie Farghaly
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1314;
  • You have access
    68Ga-DOTATATE for Neuro-Endocrine Tumor (NET) assessment: Does primary and metastatic lesion standardized uptake valuecorrelate?
    Timothy Waits, Ravi Jayavarapu, Aman Chauhan, M. Oates, Lowell Anthony and Riham El Khouli
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1330;
  • You have access
    Changes of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer
    Zhaowei Meng, Qiang Jia, Jian Tan and Ning Li
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1344;
  • You have access
    A pilot study to assess the role of early dynamic PET/CT with 18F-Fluorocholine in imaging of parathyroid adenomas
    MEGHANA PRABHU, Nishikant Damle, GARIMA KUMARI, Madhavi Tripathi, Chandrasekhar Bal, GEETANJALI Arora, PRAVEEN KUMAR, Kumar Rajeev, Rajesh Khadgawat and Devasenathipathi Kandasamy
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1326;
  • You have access
    Evaluation of Diagnostic Accuracy of 4-hour vs. 4- and 24-hour Radioactive Iodine Uptake Measurements in Thyrotoxic Patients
    Thor Farnsworth, Derek Stocker, Devon Reed, Grant Bonavia and Jennifer Jurgens
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1317;
  • You have access
    Oncogenic osteomalacia - Imaging a rare entity on 68Ga-DOTANOC PET/CT
    Ashwin Parihar, Sanjay Bhadada, Rimesh Pal, Ashwani Sood, Rajender Kumar, JAYA SHUKLA, Anish Bhattacharya and Bhagwant Mittal
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1308;
  • You have access
    Semi-automatic whole-body FDG-PET analysis could distinguish patients with aggressive disease progression causing to death within a year from long survivors in differentiated thyroid cancer patients after total thyroidectomy.
    Tohru Shiga, Yuko Uchiyama, Kenji Hirata, Shiro Watanabe, Kentaro Kobayashi, Osamu Manabe, Keiichi Magota and Nagara Tamaki
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1328;
  • You have access
    The diagnostic value of 124I PET compared to 131I imaging in differentiated thyroid cancer: systematic review and meta-analysis.
    Di Wu, Layla Heimlich, Kenneth Burman, Leonard Wartofsky and Douglas Van Nostrand
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1334;

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
SNMMI

© 2025 SNMMI

Powered by HighWire